The contract covers the early-stage development and purification of the biological vaccine candidate.
Biovian_signs_a_deal_about_COVID_19_vaccine_development_and_manufacturing
Biovian signs an agreement about early-stage development and manufacturing of a COVID-19 vaccine candidate.
Biovian has signed an agreement with a European biopharmaceutical company for contract development and manufacturing of a COVID-19 vaccine.
Latest updates
The European CMO Model, Powering Biologics Innovation
From Concept To Commercial Reality: Successful Upscaling Strategies For Viral Vector Manufacturing
Process development, scale-up and challenges of TM adenovirus GMP process in the iCELLis
Myths That Make Early CDMO Engagement Look Like A Risk
De-Risking AAV Production By Working With An End-To-End CDMO